A novel view on the mechanisms of action of insulin and other insulin superfamily peptides: Involvement of adenylyl cyclase signaling system

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 134, Issue 1, 2003, Pages 11-36

  Pertseva, M N ^a   Shpakov, A O ^a   Plesneva, S A ^a   Kuznetsova, L A ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Adenylyl cyclase mechanism; Insulin superfamily peptides; Invertebrates; Vertebrates

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE ANTAGONIST; INSULIN; ISOBUTYLMETHYLXANTHINE; PEPTIDE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; SERPENTINE; SOMATOMEDIN C; TYROSINE KINASE RECEPTOR;

CELL DEATH; DRUG EFFECT; DRUG MECHANISM; HUMAN; MAMMAL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

INVERTEBRATA; MAMMALIA; MOLLUSCA; VERTEBRATA;

EID: 0037227681     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-4959(02)00160-4     Document Type: Review

References (173)

1. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
2. Alarcon C., Morales A.V., Piementel B., Serna J., de Pablo F. (Pro)insulin and insulin-like growth factor-I complementary expression and roles in early development. Comp. Biochem. Physiol. 121:1998;13-17.
3. Alexander-Bridges M., Buggs C., Giere L., et al. Models of insulin action on metabolic and growth response genes. Mol. Cell. Biochem. 109:1992;99-105.
4. Allen D.O., Clark J.B. Effect of various antilipolytic compounds on adenylyl cyclase and phosphodiesterase activity in isolated fat cells. Adv. Enzyme Regul. 9:1971;99-112.
5. Baptist M., Dumont J.E., Roger P.P. Demonstration of cell cycle kinetics in thyroid primary culture by immunostaining of proliferating cell nuclear antigen: differences in cyclic AMP-dependent and -independent mitogenic stimulations. J. Cell. Sci. 105:1993;69-75.
6. Bartsch O., Bartlick B., Ivell R. Relaxin signaling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity. Mol. Hum. Reprod. 7:2001;799-809.
7. Begum N., Ragolia L. cAMP counter-regulates insulin-mediated protein phosphatase-2A inactivation in rat skeletal muscle cells. J. Biol. Chem. 271:1996;31166-31171.
8. Berra E., Diaz-Meco M.T., Dominguez J., et al. Protein kinase C zeta isoforms is critical for mitogenic signal transduction. Cell. 74:1993;555-563.
9. Berridge M.V., Tan A.S., Hilton C.J. Cyclic adenosine monophosphate promotes cell survival and retards apoptosis in a factor-dependent bone marrow-derived cell line. Exp. Hematol. 21:1993;269-276.
10. Bigazzi M., Brandi M.L., Bani G., Sacchi T.B. Relaxin influences the growth of MCF-7 breast cancer cells. Mitogenic and antimitogenic action depends on peptide concentration. Cancer. 70:1992;639-643.
11. Birnbaumer L. G proteins in signal transduction. Annu. Rev. Pharmacol. Toxicol. 30:1990;675-705.
12. Blakesley V.A., Scrimgeour A., Esposito D., Le Roith D. Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling? Cytokine Growth Factor Rev. 7:1996;153-159.
13. Bohni R., Riesgo-Escovar J., Oldham S., et al. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell. 97:1999;865-875.
14. Bryant-Greenwood G.D., Schwabe C. Human relaxins: chemistry and biology. Endocrinol. Rev. 15:1994;5-26.
15. Bullesbach E.E., Gang S., Schwabe C. The receptor-binding site of human relaxin II. A dual prong-binding mechanism. J. Biol. Chem. 267:1992;22957-22960.
16. Butcher R.W., Sneyd J.G.T., Park C.R., Sutherland E.W.J. Effect of insulin on adenosine-3′,5′-monophosphate in the rat epididymal fat pad. J. Biol. Chem. 241:1966;1652-1653.
17. Butcher R.W., Sutherland E.W. The effect of the catecholamines, adrenergic blocking agents, prostaglandin E1, and insulin on cyclic AMP levels in the rat epididymal fat pad in vitro. Ann. NY Acad. Sci. 139:1967;849-859.
18. Butcher R.W., Baird C.E., Sutherland E.W. Effect of lipolytic and antilipolytic substances on adenosine 3′,5′-monophosphate levels in isolated fat cells. J. Biol. Chem. 243:1968;1705-1712.
19. Butler A.A., Yakar S., Gewolb I.H., Karas M., Okubo Y., Le Roith D. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. 121:1998;19-26.
20. Chan S.J., Nagamatsu S., Cao Q.-P., Steiner D.F. Structure and evolution of insulin and insulin-like growth factors in chordates. Joosse J., Buijs R.M., Tilders F.J.H. Progress in Brain Research, vol. 92. 1992;15-24 Elsevier Science Publishers BV.
21. Chang H.S., Jeon K.W., Kim Y.H., Chung J.G., Park C.S. Role of cAMP-dependent pathway in eosinophil apoptosis and survival. Cell Immunol. 203:2000;29-38.
22. Cheatham B., Kahn C.R. Insulin action and the insulin signaling network. Endocrinol. Rev. 16:1995;117-141.
23. Chen Z., Nield H.S., Sun H., Barbier A., Patel J.P. Expression of type V adenylyl cyclase is required for epidermal growth factor-mediated stimulation of cAMP accumulation. J. Biol. Chem. 270:1995;27525-27530.
24. Chun S.Y., Eisenhauer K.M., Minami S., Billig H., Perlas E., Hsueh A.J. Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor. Endocrinology. 137:1996;1447-1456.
25. Clapham D.E. Mutations in G protein-linked receptors: novel insights on disease. Cell. 75:1993;1237-1239.
26. Cohen P. Dissection of the protein phosphorylation cascades involved in insulin action. Biochem. Soc. Trans. 21:1993;555-567.
27. Combettes-Souverain M., Issad T. Molecular basis of insulin action. Diabetes Metab. 24:1998;477-489.
28. Cronin M.J., Malaska T., Bakhit C. Human relaxin increases cyclic AMP levels in cultured anterior pituitary cells. Biochem. Biophys. Res. Commun. 148:1987;1246-1251.
29. Dekker L.V., Parker P.J. Introduction. Chapter 1. Parker P.J., Dekker L.V. Protein Kinase C. 1995;1-9 Molecular Biology Intelligence Unit, Springer.
30. Denton R.M., Tavare J.M. Does mitogen-activated protein kinase have a role in insulin action? The cases for and against. Eur. J. Biochem. 227:1995;597-611.
31. Derkach K.V., Kuznetsova L.A., Plesneva S.A., Pertseva M.N. Ontogenetic approach to the study of adenylate cyclase stimulating effect of insulin and its possible role in regulatory action of the hormone. 1997;131-137 J. Evol. Biochem. Physiol. 33, In Russian, English version.
32. Draznin B., Chang L., Leitner J.W., Takata Y., Olefsky J.M. Insulin activates p21 Ras and guanine nucleotide releasing factor in cells expressing wild type and mutant insulin receptors. J. Biol. Chem. 268:1993;19998-20001.
33. Dumont J.E., Jauniaux J.-C., Roger P.P. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 14:1989;67-71.
34. Dumont J.E., Lamy F., Roger P.P., Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72:1992;667-697.
35. Ebberink R.H.M., Smit A.B., Van Minnen J. The insulin family: evolution of structure and function in vertebrates and invertebrates. Biol. Bull. 177:1989;176-182.
36. Evan G., Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1322.
37. Exton J.H., Hardman J.G., Williams T.F., Sutherland E.W., Park C.R. Effect of guanosine 3′,5′-monophosphate on the perfused rat liver. J. Biol. Chem. 246:1971;2658-2664.
38. Fahrbach S.E. The regulation of neuronal death during insect metamorphosis: a physiological model system offers clues on how nerve cells decide to die. BioScience. 47:1997;77-79.
39. Fain J.N., Rosenberg L. Antilipolytic action of insulin on fat cells. Diabetes. 21:1972;414-425.
40. Fain J.N. Insulin as an activator of cyclic AMP accumulation in rat fat cells. J. Cyclic Nucleotide Res. 1:1975;359-366.
41. Fantl W.J., Johnson D.E., Williams L.T. Signalling by receptor tyrosine kinases. Annu. Rev. Biochem. 62:1993;453-481.
42. Fei D.T., Gross M.C., Lofgren J.L., Mora-Worms M., Chen A.B. Cyclic AMP response to recombinant human relaxin by cultured human endometrial cells - a specific and high-throughput in vitro bioassay. Biochem. Biophys. Res. Commun. 170:1990;214-222.
43. Fernandez R., Tabarini D., Azpiazu N., Frasch M., Schlessinger J. The Drosophila insulin receptor homolog: a gene essential for embryonic development encodes two receptor isoforms with different signaling potential. EMBO J. 14:1995;3373-3384.
44. Filippovich Y.B., Kutuzova N.M. The hormone regulation of metabolism in insects. Mikhailov A.I. General Results of Science and Technology, Biological Chemistry, vol. 21. 1985;VINITI, Moscow. p. 226 In Russian.
45. Frago L.M., Leon J., de la Rosa E.J., Gomes-Munoz A., Varela-Nieto I. Nerve growth factor and ceramides modulate all death in the early developing inner ear. J. Cell Sci. 111:1998;549-556.
46. Garcia-Bermejo L., Perez C., Viaboa N.E., de Bras E., Aller P. cAMP-increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells. J. Cell. Sci. 111:1998;637-644.
47. Geraerts W.P.M., Smit A.B., Li K.W., Roovers E. Insulin-related peptides in molluscs: genes, processing, functions and presumed receptors. Proceedings of 12th International Congress on Comparative Endocrinology, Toronto, Canada. 1993; Abstract A-53.
48. Goldberg N.D., Villar-Palasi C., Sasko H., Larner J. Effects of insulin treatment on muscle 3′,5′-cyclic adenylate levels in vivo and in vitro. Biochim. Biophys. Acta. 148:1967;665-672.
49. Golder M.P., Boyns A.R. Distribution of adrenocorticotropic hormone-stimulated adenylyl cyclase in the adrenal cortex. J. Endocrinol. 56:1973;471-481.
50. Gregoire F.M., Chomiki N., Kachinskas D., Warden C.H. Cloning and developmental regulation of a novel member of the insulin-like gene family in Caenorhabditis elegans. Biochem. Biophys. Res. Commun. 249:1998;385-390.
51. Guidicelli Y., Nordmann J., Nordmann R. Influence of certain effectors of cyclic AMP metabolism on the action of acetaldehyde, ethanol, and acetate on lipolysis in vitro. C.R. Acad. Sci. 274D:1972;3626-3629.
52. Gupta B.B.P. Mechanism of insulin action. Curr. Sci. 73:1997;993-1003.
53. Gutkind J.S. Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene. 17:1998;1331-1342.
54. Hedin K.E., Duerson K., Clapham D.E. Specificity of receptor-G protein interactions: searching for the structure behind the signal. Cell Signal. 5:1993;505-518.
55. Helmreich E.J., Hofmann K.P. Structure and function of proteins in G protein-coupled signaling transfer. Biochim. Biophys. Acta. 1286:1996;285-322.
56. Hepp K.D. Inhibition of glucagon-stimulated adenylyl cyclase by insulin. FEBS Lett. 12:1971;263-266.
57. Hepp K.D. Adenylate cyclase and insulin action. Effect of insulin, non-suppressible insulin-like material, and diabetes on adenylate cyclase. Eur. J. Biochem. 31:1972;266-276.
58. Hetenyi G., Singhal R.L. Effect of insulin on cerebral adenylyl cyclase and phosphodiesterase. Horm. Metab. Res. 5:1973;139.
59. Ho R.-J., Russel T.R., Asakawa T., Sutherland E.W. Cellular levels of feedback regulator of adenylate cyclase and the effect of epinephrine and insulin. Proc. Natl. Acad. Sci. USA. 75:1975;4739-4743.
60. Houslay M.D. Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver. Twenty-second Colworth medal lecture. Biochem. Soc. Trans. 14:1986;183-193.
61. Houslay M.D. The use of selective inhibitors and computer modeling to evaluate the role of specific high-affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrations. Cell. Signal. 2:1990;85-98.
62. i-2 is at the centre of an active phosphorylation/dephosphorylation cycle in hepatocytes: the fine-tuning of stimulatory and inhibitory inputs into adenylate cyclase in normal and diabetic states. Cell. Signal. 3:1991;1-9.
63. Houslay M.D., Milligan G. Tailoring cAMP signaling responses through isoform multiplicity. Trends Biochem. Sci. 22:1997;217-224.
64. Illiano G., Cuatrecasas P. Modulation of adenylate cyclase activity in liver and fat cell membranes by insulin. Science. 175:1972;906-908.
65. Ishikawa J., Homcy C.J. The adenylyl cyclases as integrators of transmembrane signal transduction. Circ. Res. 80:1997;297-304.
66. Ito Y., Uchijima Y., Ariga M., et al. Interaction between cAMP-dependent and insulin-dependent signal pathways in tyrosine phosphorylation in primary cultures of rat hepatocytes. Biochem. J. 324:1997;379-388.
67. Jacobson M.D. Programmed cell death: a missing link is found. Trends Cell Biol. 7:1997;467-469.
68. Jarett L., Steiner A.L., Smith R.M., Kipnis D.M. The involvement of cyclic AMP in the hormonal regulation of protein synthesis in rat adipocytes. Endocrinology. 90:1972;1277-1284.
69. Jones J.L., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;3-34.
70. Kawabe J.-I., Ebina T., Toya Y., Oka N., Schwencke C., Duzic E. Regulation of type V adenylyl cyclase by PMA-sensitive and insensitive protein kinase C isoenzymes in intact cells. FEBS Lett. 384:1996;273-276.
71. Kawabe J., Iwami G., Ebina T., et al. Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J. Biol. Chem. 269:1994;16554-16558.
72. Knol J.C., Weidemann W., Planta R.J., Vreugdenhil E., Heerikhuizen H. Molecular cloning of G protein α-subunits from the central nervous system of the mollusc Lymnaea stagnalis. FEBS Lett. 314:1992;215-219.
73. Knol J.C., van der Slik A.R., van Kesteren E.R., Planta R.J., Heerikhuizen H., Vreugdenhil E. A novel G protein subunit containing atypical guanine nucleotide-binding domains is differentially expressed in a molluscan nervous system. J. Biol. Chem. 270:1995;18804-18808.
74. Kojima I., Kitaoka M., Ogata E. Studies on the cell-cycle dependence of the actions of insulin-like growth factor I in Balb/c 3T3 cells. J. Cell. Physiol. 143:1990;529-533.
75. Kono T., Barham F.W. Effect of insulin on the levels of adenosine 3′,5′-monophosphate and lipolysis in isolated rat epididymal fat cells. J. Biol. Chem. 248:1973;7417-7426.
76. Kramer S.M., Gibson V.E.M., Fendly B.M., Mohler M.A., Drolet D.W., Johnston P.D. Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell culture. In Vitro Cell. Dev. Biol. 26:1990;647-656.
77. Krupinski J., Lehman T.C., Frankenfield C.D. Molecular diversity in the adenylyl cyclase family. Evidence for eight forms of the enzyme and cloning of type VI. J. Biol. Chem. 267:1992;24858-24862.
78. Kulik G., Klippel A., Weber M.J. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol-3-kinase, and Akt. Mol. Cell Biol. 17:1997;1595-1606.
79. i2 in human intestinal smooth muscle: Gβγ-dependent MAP kinase activation and growth. J. Biol. Chem. 276:2001;7187-7194.
80. Kuznetsova L., Plesneva S., Derjabina N., Omeljaniuk E., Pertseva M. On the mechanism of relaxin action: the involvement of adenylyl cyclase signaling system. Regul. Peptides. 80:1999;33-39.
81. Lawrence C.B., Goldman D.A. Definition and identification of homology domains. Comput. Appl. Biosci. 4:1988;25-33.
82. Lazar D.F., Wiese R.J., Brady M.J., et al. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J. Biol. Chem. 270:1995;20801-20807.
83. Leibush B.N. Receptors of insulin and insulin-like growth factor 1: pathways of structural and functional divergence of two evolutionary related molecules. J. Evol. Biochem. Physiol. 34:1998;62-71 In Russian, English version.
84. Leibush B., Bayraktaroglu E., Maestro M.A., Banos N., Navarro I., Gutierrez J. IGF-I and insulin binding in molluscs. Abstracts of 18th Conference of European Comparative Endocrinologists from Molecular to Integrative Biology, Ann. d'Endocrinol. 57, Suppl. N 4. 1996;28-29.
85. Li S., Resnicoff M., Baserga R. Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor-I receptor. J. Biol. Chem. 271:1996;12254-12260.
86. Lin W.-W., Chang S.-H., Wang S.-M. Role of atypical protein kinase C in lysophosphatidic acid-induced type II adenylyl cyclase activation in RAW2647 macrophages. Br. J. Pharmacol. 128:1999;1189-1198.
87. Liu W.S., Heckman C.A. The seven-fold way of PKC regulation. Cell Signal. 10:1998;529-542.
88. Lizcano J.M., Morrice N., Cohen P. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site. Biochem. J. 349:2000;547-557.
89. Lopaczynski W. Differential regulation of signaling pathways for insulin and insulin-like growth factor I. Acta Biochim. Pol. 46:1999;51-60.
90. Loten E.G., Sneyd J.G.T. Effect of insulin on adipose tissue adenosine 3,5-cyclic monophosphate phosphodiesterase. Biochem. J. 120:1970;187-195.
91. Luft F.C. G proteins and insulin signaling. J. Mol. Med. 75:1997;233-235.
92. q. J. Biol. Chem. 268:1993;13900-13905.
93. Makino H., Taira M., Shimada F. Insulin receptor gene mutation: a molecular, genetical and functional analysis. Cell Signal. 4:1992;351-363.
94. Manganiello V.C., Murad F., Vaughan M. Effects of lipolytic and anti-lipolytic agents on cyclic 3′,5′-adenosine monophosphate in fat cells. J. Biol. Chem. 246:1971;2195-2202.
95. McLachlan A.D. Tests for comparing related amino acid sequences. Cytochrome c and cytochrome c551. J. Mol. Biol. 61:1971;409-424.
96. Merlo G.R., Graus-Porta D., Cella N., Marte B.M., Taverna D., Hynes N.E. Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factor. Eur. J. Biochem. 70:1996;97-105.
97. Mhaouty-Kodja S., Bonet-Alard R., Limon-Boulez J., Maltier J.P., Legrand C. Molecular diversity of adenylyl cyclases in human and rat myometrium. Correlation with global adenylyl cyclase activity during mid- and term pregnancy. J. Biol. Chem. 272:1997;31100-31106.
98. Morris A.J., Malbon C.C. Physiological regulation of G protein-linked signaling. Physiol. Rev. 79:1999;1373-1430.
99. Murray-Rust J., Macleod A.N., Blundell T.L., Wood S.P. Structure and evolution of insulins: implications for receptor binding. BioEssays. 14:1992;325-331.
100. s mediates epidermal growth factor-elicited stimulation of rat cardiac adenylate cyclase. J. Biol. Chem. 265:1990;21317-21332.
101. Nair B.G., Patel T.B. Regulation of cardiac adenylate cyclase by epidermal growth factor (EGF). Role of EGF receptor protein tyrosine kinase activity. Biochem. Pharmacol. 46:1993;1239-1245.
102. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 80:1995;249-257.
103. Nixon J.S. The biology of protein kinase C inhibitors. Parker P.J., Dekker L.V. Protein Kinase C. 1997;205-229 Springer-Verlag, Heidelberg.
104. O'Brien R.M., Granner D.K. Regulation of gene expression by insulin. Physiol. Rev. 76:1996;1109-1161.
105. o. FEBS Lett. 212:1987;281-288.
106. O'Connor R. Survival factors and apoptosis. Adv. Biochem. Eng. Biotechnol. 62:1998;137-166.
107. Okamoto T., Nishimoto I. Analysis of stimulation G protein subunit coupling by using active insulin-like growth factors II receptor peptide. Proc. Natl. Acad. Sci. USA. 88:1991;8020-8023.
108. Okamoto J., Okamoto T., Murayama Y., Hayashi Y., Ogata E., Nishimoto I. GTP-binding protein-activator sequences in the insulin receptor. FEBS Lett. 334:1993;143-148.
109. Orlov S.N., Thorin-Trescases N., Dulin N.O., et al. Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3. Cell Death Differ. 6:1999;661-672.
110. Pae H.O., Seo W.G., Shin M., et al. Protein kinase A or C modulates the apoptosis induced by lectin II isolated from Korean mistletoe, Vescum album var. coloratum, in the human leukemic HL-60 cells. Immunopharmacol. Immunotoxicol. 22:2000;279-295.
111. Paradis S., Ailion M.A., Toker A., Thomas J.H., Ruvkun G. A PDK1 homolog is necessary and sufficient to transduce AGE-1, PI3 kinase, signals that regulate diapause in Caenorhabditis elegans. Genes Dev. 13:1999;1438-1452.
112. Parrizas M., Saltiel A.R., LeRoith D. Insulin-like growth factor-I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272:1997;154-161.
113. Park C.R., Sneyd J.G.T., Corbin J.D., Jefferson L.S., Exton J.H. Role of cyclic adenylate in the actions of insulin. Ostman J. Diabetes. 1967;5-15 Excerpta Medical Foundation, Amsterdam, Netherlands.
114. Parsell D.A., Mak J.J., Amento E.P., Unemori E.N. Relaxin binds to and elicits a response from cells of the human monocytic cell line, THP-1. J. Biol. Chem. 271:1996;27936-27941.
115. Parvathenani L.K., Buescher E.E., Chacon-Cruz E., Beebe S.J. Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3. J. Biol. Chem. 273:1998;6736-6743.
116. Pertseva M.N. Molecular Basis of Evolution of Cell Hormonocompetence. 1989;Nauka, Leningrad. p. 251 In Russian.
117. Pertseva M.N. Evolutionary approach in the study of signalling mechanisms of insulin action. Abstracts of the XXXIIIth International Congress of Physiological Sciences. 1997;. L072.01.
118. Pertseva M.N. Contribution of evolutionary endocrinology to study of the insulin structure and mechanisms. J. Evol. Biochem. Physiol. 35:1999;233-240 In Russian, English version.
119. Pertseva M.N. Hypothesis about the key coordinating role of adenylate cyclase signaling mechanism and of cAMP in regulatory action of peptides of the insulin superfamily on fundamental cellular processes: cell growth, apoptosis, metabolism. J. Evol. Biochem. Physiol. 36:2000;641-654 In Russian, English version.
120. Pertseva M.N., Kuznetsova L.A., Plesneva S.A., Grishin A.V., Panchenko M.P. β-Agonist-induced inhibitory-guanine-nucleotide-binding regulatory protein coupling to adenylate cyclase in mollusc Anodonta cygnea foot muscle sarcolemma. Eur. J. Biochem. 210:1992;279-286.
121. Pertseva M.N., Plesneva S.A., Shpakov A.O., Rusakov Y.I., Kuznetsova L.A. Involvement of adenylyl cyclase signaling system in the action of insulin and mollusc insulin-like peptide. Comp. Biochem. Physiol. 112:1995;689-695.
122. Pertseva M.N., Shpakov A.O., Plesneva S.A. Current advances in studies of signaling mechanisms of action of insulin and related peptides. J. Evol. Biochem. Physiol. 32:1996a;259-277 In Russian, English version.
123. Pertseva M.N., Plesneva S.A., Kuznetsova L.A., Shpakov A.O., Derkach K.V. On the tyrosine kinase mechanism of the novel effect of insulin and insulin-like growth factor I. Stimulation of the adenylyl cyclase system in muscle tissues. Biochem. Pharmacol. 52:1996b;1867-1874.
124. Plesneva S.A., Jalovetsky A.V., Kuznetsova L.A., Sokolov I.N., Matyushichev V.B., Pertseva M.N. On a new mechanism of insulin signal transduction: participation of adenylyl cyclase signal system in growth stimulating effect of insulin. J. Evol. Biochem. Physiol. 34:1998;529-538 In Russian, English version.
125. Plesneva S.A., Barkan R.S., Reshetnikova G.F., Kuznetsova L.A., Pertseva M.N. Adenylyl cyclase signaling mechanism in mitogenic action of insulin, insulin-like growth factor I and epidermal growth factor. Dokl. Akad. Nauk (Dokl. Biochem.). 368:(6):1999;833-835 In Russian.
126. Plesneva S.A., Kuznetsova L.A., Shpakov A.O., Pertseva M.N. Adenylyl cyclase signaling mechanism is involved in the action of insulin in vivo in tissues and cells of vertebrates and invertebrates. Proceedings of the 5th International Congress of Comparative Physiology and Biochemistry (ICCPB '99), Canada. 1999; Abstract P1-24.
127. Plesneva S.A., Shpakov A.O., Kuznetsova L.A., Pertseva M.N. A dual role of protein kinase C in insulin signal transduction via adenylyl cyclase signaling system in muscle tissues of vertebrates and invertebrates. Biochem. Pharmacol. 61:2001;1277-1291.
128. Plesneva S.A., Shpakov A.O., Rusakov Y.I., Kuznetsova L.A., Pertseva M.N. The involvement of adenylate cyclase signaling system in the action of insulin, epidermal growth factor and insulin-like peptide of mollusk. Roubos E.W. Proceedings of 17th Conference of European Comparative Endocrinologists, Universidad Cordoba, Spain, 5-10 September, 1994, Abstract 135. 1994;1994 University Press, Cordoba.
129. s by the epidermal growth factor receptor involves phosphorylation. J. Biol. Chem. 271:1996;6947-6951.
130. Price S.A., Pochun J., Phaneuf S., Bernal A.L. Expression of adenylyl cyclase isoforms in pregnant and non-pregnant human myometrium. Biochimie. 81:1999;S382.
131. Ray T.K., Tomasi V., Marinetti G.V. Hormone action at the membrane level. I. Properties of adenylyl cyclase in isolated plasma membranes of rat liver. Biochim. Biophys. Acta. 211:1970;20-30.
132. Robison G.A., Park C.R. Cyclic adenylate in mammalian tissues. Diabetes Mellitus: Theory, Practice. 1970;132-149.
133. Roger P.P., Reuse S., Maenhaut C., Dumont J.E. Multiple facets of the modulation of growth by cAMP. Vitam. Horm. 51:1995;59-191.
134. Roovers J.F.A., Vincent M.E., van Kesteren E., et al. Characterization of a putative molluscan insulin-related peptide receptor. Gene. 162:1995;181-188.
135. Rusakov Y.I., Bondareva V.M., Karasev V.S., Leibush B.N., Barkan R.S., Pertseva M.N. Some biochemical characteristics of an insulin-like substance of the bivalve mollusk Anodonta cygnea. Biokhimiya. 56:1991;718-726 In Russian.
136. Saltiel A.R. Diverse signaling pathways in the cellular actions of insulin. Am. J. Physiol. 270:1996;E375-E385.
137. Samiei H.V. Signaling in new directions. Biochem. Cell. Biol. 73:1995;133-136.
138. Schwabe C., Bullesbach E.E. Relaxin: structure, functions, promises, and non-evolution. FASEB J. 8:1994;1152-1160.
139. Shpakov A.O. The search for homologous sequences in the primary structure of dolichol-coupled enzymes. J. Evol. Biochem. Physiol. 31:1995;133-140 In Russian, English version.
140. Shpakov A.O. Molecular basis of the functional coupling of receptors to GTP-binding proteins. Membr. Cell Biol. 9:1996a;467-488.
141. Shpakov A.O. Molecular determinants of receptors and GTP-binding proteins determining specificity of their interactions. J. Evol. Biochem. Physiol. 32:1996b;400-418 In Russian, English version.
142. Shpakov A.O. The homology of the primary structure of the third cytoplasmic domains in rhodopsin-type receptors and of the cytoplasmic tail in the β-subunit of the insulin receptor. Tsitologiya. 38:1996c;1179-1190 In Russian.
143. Shpakov A.O. Structure-functional characteristics of heterodimeric phosphatidylinositol-3-kinase and molecular mechanisms of its conjugation with other components of signaling system. Tsitologiya. 41:1999;975-991 In Russian.
144. Shpakov A.O., Pertseva M.N. Structural-functional characterization of GTP-binding proteins in invertebrate animals. J. Evol. Biochem. Physiol. 29:1993;399-409 In Russian, English version.
145. Shpakov A.O., Pertseva M.N. Structural-functional characteristics of β- and γ-subunits of G proteins and molecular mechanisms of their conjugation with other components of the signal transduction system. J. Evol. Biochem. Physiol. 33:1997;669-688 In Russian, English version.
146. Shpakov A.O., Pertseva M.N. Structural and functional characterization of insulin receptor substrate proteins and the molecular mechanisms of their interaction with insulin superfamily tyrosine kinase receptors and effector proteins. Membr. Cell Biol. 13:2000;455-484.
147. Singleton J.R., Dixit V.M., Feldman E.L. Type 1 insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem. 271:1996;31791-31794.
148. Skorokhod A., Gamulin V., Gundacker D., Kavsan V., Muller I.M., Muller W.E.G. Origin of insulin receptor-like tyrosine kinases in marine sponges. Biol. Bull. 197:1999;198-206.
149. Smit A.B., Van Marle A., Van Elk R., Bogerd J., Van Heerikhuizen H., Geraerts W.P. Evolutionary conservation of the insulin gene structure in invertebrates: cloning of the gene encoding molluscan insulin-related peptide III from Lymnaea stagnalis. J. Mol. Endocrinol. 11:1993;103-113.
150. Smit A.B., Van Kesteren R.E., Li K.W., et al. Towards understanding the role of insulin in the brain: lessons from insulin-related signaling systems in the invertebrate brain. Prog. Neurobiol. 54:1998;35-54.
151. Sneyd J.G.D., Corbin J.D., Park C.R. The role of cyclic AMP in the action of insulin. Adv. Exp. Med. Biol. 2:1967;367-376.
152. 2+-independent protein kinase C, Apl II, through a wortmannin-sensitive signaling pathway in Aplysia. J. Neurochem. 67:1996;220-228.
153. Srinivasan M., Begum N. Regulation of protein phosphatase 1 and 2A activates by insulin during myogenesis in rat skeletal muscle cells in culture. J. Biol. Chem. 269:1994;12514-12520.
154. Standaert M.L., Galloway L., Karnam P., Bandyopadhyay G., Moscat J., Farese R.V. Protein kinase C-zeta as a downstream effector of phosphatidylinositol-3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J. Biol. Chem. 272:1997;30075-30082.
155. Standaert M.L., Bandyopadhyay G., Kanoh Y., Sajan M.P., Farese R.V. Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites. Biochemistry. 40:2001;249-255.
156. Steiner D.F., Chan S.J., Docherty K., et al. Evolution of polypeptide hormones and their precursor processing mechanism. Falkmer S., Hakanson R., Sandler F. Evolution and Tumor Pathology of the Neuroendocrine System, vol. 12. 1984;203-223 Elsevier Science Publishers BV.
157. Sun H., Seyer J.M., Patel T.B. A region in the cytosolic domain of the epidermal growth factor receptor antithetically regulates the stimulatory and inhibitory guanine nucleotide-binding regulatory proteins of adenylyl cyclase. Proc. Natl. Acad. Sci. USA. 92:1995;2229-2233.
158. Tang W.-J., Gilman A.G. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science. 254:1991;1500-1503.
159. Taussig R., Gilman A.G. Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem. 270:1995;1-4.
160. Taylor S.I., Cama A., Accili D., et al. Mutations in the insulin receptor gene. Endocrinol. Rev. 13:1992;566-595.
161. Tepperman J. Metabolic and Endocrine Physiology. 4th Edition :1981;237-238 Year Boon Medical Publishers Inc, Chicago, London.
162. Trovati M., Massucco P., Mattiello L., et al. Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. Diabetologia. 38:1995;936-941.
163. Van Keymeulen A., Dumont J.E., Roger P.P. TSH induces insulin receptors that mediate insulin costimulation of growth in normal human thyroid cells. Biochem. Biophys. Res. Commun. 279:2000;202-207.
164. Webster C.R., Anwer M.S. Cyclic adenosine monophosphate mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology. 27:1998;1324-1331.
165. Wess J. Molecular basis of receptor/G protein-coupling selectivity. Pharmacol. Ther. 80:1998;231-264.
166. i in insulin signal transduction. Biochem. Biophys. Res. Commun. 196:1993;287-293.
167. White M.F., Kahn C.R. The insulin signalling system. J. Biol. Chem. 269:1994;1-4.
168. Whitehead J.P., Clark S.F., Urso B., James D.E. Signalling through the insulin receptor. Curr. Opin. Cell Biol. 12:2000;222-228.
169. Wilson M.R. Apoptotic signal transduction: emerging pathways. Cell Biol. 76:1998;573-582.
170. i-coupled receptors. J. Biol. Chem. 271:1996;8537-8540.
171. iα subunits of heterotrimeric G proteins. Proc. Natl. Acad. Sci. USA. 96:1999;9551-9556.
172. Yano H., Nakanishi S., Kimura K., et al. Inhibition of histamine secretion by wortmannin through the blockage of phosphatidylinositol-3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:1993;25846-25856.
173. Zimmermann G., Taussig R. Protein kinase C alters the responsiveness of adenylyl cyclases to G protein α and βγ subunits. J. Biol. Chem. 271:1996;27161-27166.